Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden flag Sweden · Delayed Price · Currency is SEK
17.18
-0.28 (-1.60%)
At close: Aug 1, 2025

Accolade Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
800995----
Upgrade
Enterprise Value
276351----
Upgrade
Last Close Price
17.1821.38----
Upgrade
PS Ratio
174.57217.24----
Upgrade
PB Ratio
1.561.79----
Upgrade
P/TBV Ratio
1.561.79----
Upgrade
EV/Sales Ratio
60.2676.67----
Upgrade
Debt / Equity Ratio
0.000.00-1.710.000.01-
Upgrade
Asset Turnover
0.020.010.040.06--
Upgrade
Quick Ratio
12.0412.620.563.997.1732.17
Upgrade
Current Ratio
12.7113.200.574.017.4732.74
Upgrade
Return on Equity (ROE)
-83.22%-70.23%-859.20%-196.14%-45.79%-39.33%
Upgrade
Return on Assets (ROA)
-36.72%-30.36%-89.35%-79.11%-29.29%-21.50%
Upgrade
Return on Capital (ROIC)
-41.29%-34.63%-137.82%-102.90%-31.49%-22.49%
Upgrade
Earnings Yield
-20.61%-16.89%----
Upgrade
FCF Yield
--17.93%----
Upgrade
Buyback Yield / Dilution
-60.52%-41.26%-13.81%-9.26%-8415.70%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.